Ken focuses on developing collaborations with companies that have the market presence and capabilities to help realize HST’s commercial potential. He has been involved with other technology-driven companies as a financial advisor and Board member. He helped to organize the predecessor company of Dendritic Nanotechnologies, Inc. and served on its Board of Directors, prior to Dow Chemical’s minority investment and the subsequent acquisition by Starpharma Holdings.

Ken has been actively involved in mergers and acquisitions and financings for over twenty years. Prior to forming Nanovate LLC, a financial advisory business, Mr. Wang was a director and vice president in chemical industry and M&A product groups at JPMorgan and CS First Boston. He holds a B.S. and a S.M. degree in Chemical Engineering from Cornell University and from the Massachusetts Institute of Technology, respectively, and an M.B.A. with concentration in Finance from The Wharton School, University of Pennsylvania.





 

   


Hybrid Silica Technologies, Inc. (HST) develops nanostructured silica materials with an emphasis on fluorescent core-shell silica nanoparticles. These advanced materials have great potential in bio-imaging, diagnostics, sensors, development tools for drug discovery and related areas in life sciences. Other applications have also emerged in a broad range of industries including consumer, energy and electronics.

C•spec® particles synthesized here are being investigated in joint research programs at Cornell’s campus in Ithaca, New York and at Cornell’s Weill Medical College in Manhattan as well as at other high-profile research institutions including Memorial Sloan-Kettering Center and the National Institute of Health. Hybrid materials are being developed in collaboration with government agencies including the Department of Homeland Security and the U.S. Army as well as with commercial partners worldwide.

HST provides customized C•spec® particles to supply reagents to collaborators at these institutions and companies. HST does not sell uncoated particles as a standalone product but does sell coated, functionalized and conjugated C•spec® particles for specific applications.